Androclus.com
Title
Welcome to Androclus Therapeutics
Description
Excerpted from the website:
- Androclus Therapeutics is a clinical-stage biotechnology company developing first-in-class selective therapeutics for the treatment of autoimmune diseases, including rheumatoid arthritis (RA), multiple sclerosis (MS) and inflammatory bowel disease (IBD), based on a proprietary epitope-specific immunotherapy technology platform. The breakthrough technology platform has a potential of producing the next generation of safer, orally administered therapeutics.
- Currently available biologics for the treatment of autoimmune diseases are typically associated with long-term safety risks due to broad immunosuppression, have an inconvenient parenteral route of administration and high cost. Androclus' drug candidates are designed to provide improved treatment options to patients by offering increased selectivity in targeting chronic autoimmune inflammation without broad immunosuppression, an improved tolerability and safety profile, more convenient oral route of administration, and lower cost of goods.
Additional Information
Domain Resolution
This domain resolves to the following IP addresses:
Categories:
- Aids
- Auto Immune
- Autoimmunity
- Biotechnology And Pharmaceuticals
- Bowel Disease
- California
- Cancer
- Clinical Trial
- Diabetes
- Disease
- Hiv
- Heat Shock Proteins
- Immune
- Immune Mediated Diseases
- Immunology
- Immunomodulation
- Immunomodulatory Peptides
- Immunotherapy
- Industrial
- Inflammatory Bowel Disease
- Inflammatory Disease
- Juvenile Idiopathic Arthritis
- Mediated
- Mediated Disease
- Multiple Sclerosis
- Oral Tolerance
- Pan Dr Binder
- Peptides
- Regulating
- Research
- Rheumatoid Arthritis
- San Diego
- Systemic Lupus Erythematosus
- T Cells
- Transplant
- Type I Diabetes
- United States
- AIDS
- Autoimmune
- Biotechnology and Pharmaceuticals
- Business and Economy
- HIV
- Localities
- North America
- Pan-DR Binder
- Regional